Forte Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $32,476,999.

Profit Margin

Forte Biosciences, Inc. (NASDAQ:FBRX): Profit margin
2015 51K -23.05M -45207.84%
2016 49K -33.47M -68322.45%
2017 41K -38.92M -94948.78%
2018 18.03M -48.95M -271.43%
2019 0 -4.06M
2020 0 -78.54M
2021 0 -21.70M
2022 0 -13.86M
2023 0 -31.47M

FBRX Income Statement (2015 โ€“ 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0000018.03M41K49K51K
Cost of revenue
9K036K54K11K0000
Gross profit
-9K0-36K-54K-11K18.03M41K49K51K
Operating exp.
Research and development
21.86M5.59M13.85M10.00M2.68M51.08M29.11M27.21M19.17M
Selling and marketing
-9K00000-292K0-232K
Total operating expenses
32.47M13.89M21.48M14.22M4.06M63.88M37.37M31.69M22.77M
Operating income
-32.48M-13.89M-21.48M17.83M-4.06M-45.85M-37.62M-31.64M-22.95M
Other income (expenses), net
1.00M17K-222K-205K-4.33K-1.40M-1.3M-1.83M-102K
Income before tax
-31.47M-13.87M-21.70M-46.48M-4.06M-47.25M-38.92M-33.47M-23.05M
Income tax expense
0-17K032.05M-2.52K1.69M-2.6M-3.67M-204K
Net income
-31.47M-13.86M-21.70M-78.54M-4.06M-48.95M-38.92M-33.47M-23.05M
Earnings per share
Basic EPS
-24.92-0.8-1.55-157.92-1.93-36.61-997.5-27.14-474.15
Diluted EPS
-24.92-0.8-1.55-157.92-1.93-36.61-997.5-27.14-474.15
Data sourceData sourceData sourceData sourceData sourceData sourceData source